✦ LIBER ✦

Phase I Clinical and Pharmacological Studies of 20-(S)-Camptothecin and 20-(S)-9-Nitrocamptothecin as Anticancer Agents

✍ Scribed by ETHAN A. NATELSON; BEPPINO C. GIOVANELLA; CLAIRE F. VERSCHRAEGEN; KIM M. FEHIR; PETER D. DE IPOLYI; NICK HARRIS; JOHN S. STEHLIN

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparative molecular field analysis and

✍ Sean W. Carrigan; Peter C. Fox; Monroe E. Wall; Mansukh C. Wani; J. Phillip Bowe 📂 Article 📅 1997 🏛 Springer Netherlands 🌐 English ⚖ 117 KB

Feasibility, Phase I, and Pharmacologica

✍ C. F. VERSCHRAEGEN; B. E. GILBERT; A. J. HUARINGA; R. NEWMAN; N. HARRIS; F. J. L 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 981 KB

Phase I Study of 9-Nitro-20(S)-Camptothe

✍ C. F. VERSCHRAEGEN; M. VINCENT; J. L. ABBRUZZESE; D. SIEGLER; J. J. KAVANAGH; E. 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 146 KB

A phase I study of concurrent 9-nitro-20

✍ Karen L. Tedesco; Jordan Berlin; Mace Rothenberg; Hak Choy; Ken Wyman; Adrian Sc 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 85 KB

Clinical Evaluation of the Delivery and

✍ Verschraegen, C. F. 📂 Article 📅 2004 🏛 American Association for Cancer Research 🌐 English ⚖ 273 KB

Magnetic, phase transformation and magne

✍ Babita, I; Gopalan, R; Ram, S 📂 Article 📅 2009 🏛 Institute of Physics 🌐 English ⚖ 596 KB